Open Access
| Issue |
Med Sci (Paris)
Volume 35, Number 12, Décembre 2019
Anticorps monoclonaux en thérapeutique
|
|
|---|---|---|
| Page(s) | 993 - 996 | |
| Section | Anticorps monoclonaux : quand les cellules de l’immunité s’en mêlent | |
| DOI | https://doi.org/10.1051/medsci/2019196 | |
| Published online | 06 January 2020 | |
- Victora GD, Nussenzweig MC. Germinal centers. Annu Rev Immunol 2012 ; 30: 429–457. [CrossRef] [PubMed] [Google Scholar]
- Mouquet H.. Antibody B cell responses in HIV-1 infection. Trends Immunol 2014 ; 35: 549–561. [CrossRef] [PubMed] [Google Scholar]
- Gruell H, Klein F. Antibody-mediated prevention and treatment of HIV-1 infection. Retrovirol 2018 ; 15: 73. [CrossRef] [Google Scholar]
- Gautam R, Nishimura Y, Gaughan N, et al. A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection. Nat Med 2018 ; 24: 610–616. [CrossRef] [PubMed] [Google Scholar]
- Falkenhagen A, Joshi S. Genetic strategies for HIV treatment and prevention. Mol Ther Nucleic Acids 2018 ; 13: 514–533. [Google Scholar]
- Kuhlmann AS, Haworth KG, Barber-Axthelm IM, et al. Long-term persistence of anti-HIV broadly neutralizing antibody-secreting hematopoietic cells in humanized mice. Mol Ther 2019 ; 27: 164–177. [CrossRef] [PubMed] [Google Scholar]
- Gaj T, Gersbach CA, Barbas CF. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 2013 ; 31: 397–405. [CrossRef] [PubMed] [Google Scholar]
- Croteau FR, Rousseau GM, Moineau S. Le système CRISPR-Cas: au-delà de l’édition génomique. Med Sci (paris) 2018 ; 34: 813–819. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Voss JE, Gonzalez-Martin A, Andrabi R, et al. Reprogramming the antigen specificity of B cells using genome-editing technologies. eLife 2019; 8: e42995. [CrossRef] [PubMed] [Google Scholar]
- Pogson M, Parola C, Kelton WJ, et al. Immunogenomic engineering of a plug-and-(dis)play hybridoma platform. Nat Commun 2016 ; 7: 12535. [PubMed] [Google Scholar]
- Moffett HF, Harms CK, Fitzpatrick KS, et al. B cells engineered to express pathogen-specific antibodies protect against infection. Science Immunol 2019; 4: eaax0644. [CrossRef] [Google Scholar]
- Hartweger H, McGuire AT, Horning M, et al. HIV-specific humoral immune responses by CRISPR-Cas9-edited B cells. J Exp Med 2019 ; 216: 1301–1310. [CrossRef] [PubMed] [Google Scholar]
- Greiner V, Bou Puerto R, Liu S, et al. CRISPR-mediated editing of the B cell receptor in primary human B cells. iScience 2019; 12: 369–78. [CrossRef] [PubMed] [Google Scholar]
- Cheong T-C, Compagno M, Chiarle R. Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system. Nat Commun 2016 ; 7: 10934. [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.